Bladder Cancer Trial, Recruiting (NCT06977906)

Bladder Cancer Trial, Recruiting NCT06977906 Sponsor: First Affiliated Hospital of Fujian Medical University Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06977906 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with high-risk prostate cancer confirmed by a biopsy and at least one of the following: a PSA level above 20 ng/mL, a Gleason score of 8 or higher, or a specific stage of tumor spread (confirm with trial site), and you have had or are planned to have robotic-assisted surgical removal of the prostate
You have had a specific type of detailed MRI scan (called multiparametric MRI) using a 3.0 Tesla scanner at the trial center within 30 days before your surgery
You are generally active and able to carry out daily activities with little to no limitation (confirm with trial site for exact fitness level required)
Your full medical records and biopsy results are available and complete
You are in good general health with no active infections, autoimmune conditions, blood disorders, or other cancers

Who may not be able to join:

You have a medical reason that makes surgery unsafe or not possible for you
You are not willing to have the contrast-enhanced MRI scan required for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613235907575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06977906

Sponsor: First Affiliated Hospital of Fujian Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: +8613235907575

More information: https://clinicaltrials.gov/study/NCT06977906

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with high-risk prostate cancer confirmed by a biopsy and at least one of the following: a PSA level above 20 ng/mL, a Gleason score of 8 or higher, or a specific stage of tumor spread (confirm with trial site), and you have had or are planned to have robotic-assisted surgical removal of the prostate
You have had a specific type of detailed MRI scan (called multiparametric MRI) using a 3.0 Tesla scanner at the trial center within 30 days before your surgery
You are generally active and able to carry out daily activities with little to no limitation (confirm with trial site for exact fitness level required)
Your full medical records and biopsy results are available and complete
You are in good general health with no active infections, autoimmune conditions, blood disorders, or other cancers

Who may not be able to join:

You have a medical reason that makes surgery unsafe or not possible for you
You are not willing to have the contrast-enhanced MRI scan required for the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

First Affiliated Hospital of Fujian Medical University

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

1 January 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

rate of continence; The degree of bladder descent

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov